Cloud DX was founded on September 15th, 2014 by Robert Kaul, CEO, Anthony Kaul, COO and Dr. Sonny Kohli, Medical Co-founder.

The Qualcomm Tricorder XPRIZE was a $10 million global competition to incentivize the development of innovative technologies capable of accurately diagnosing a set of 13 medical conditions independent of a healthcare professional or facility, ability to continuously measure 5 vital signs, and have a positive consumer experience. Cloud DX was the winner of the XPRIZE’s first Bold Epic Innovator Award in recognition of exponential technological progress in the field of consumer-focused medical technologies, and potential for expanding access to healthcare when deployed at scale.

Yes, Cloud DX has 12 granted patents and a growing list of pending patents on our hardware and software solutions.

Yes, Cloud DX remote patient monitoring is reimbursed in both Canada and the United States by public and private health insurance.

Yes, all of Cloud DX's healthcare products are approved, licensed, or cleared for sale by regulators in Canada and the USA. In addition, Cloud DX is certified for Quality Management to ISO 13485 standards.

Yes, for more information on Cloud DX publications please go to our main website clouddx.com or email investor.relations@clouddx.com.

Management & Insiders hold ~41% of the issued and outstanding shares.

Currently Cloud DX has 40+ full time employees and growing.

Cloud DX has offices in both Canada and the US.

100 - 72 Victoria Street South

Kitchener, ON

N2G 4Y9

Canada

824 – 20 Jay Street

Brooklyn, New York

11201

USA

This idea is under consideration and will be announced when any decision is made.

Currently Cloud DX operates as a B2B (Business to Business) and B2G (Business to Government) vendor to clinics, hospitals, academic medical centres and governments across North America.